QTREX Quantum Ltd.

QTEX ·Healthcare, Medical Devices
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023
Revenue $289.0K $0 $0
Cost of Revenue $287.0K $0 $0
Gross Profit $2.0K $0 $0
Gross Margin 0.7% — —
Operating Expenses
Research & Development $7.5M $6.3M $7.3M
SG&A Expense $5.5M $4.2M $4.1M
Operating Income $-13.6M $-11.3M $-12.1M
Operating Margin -4,713.8% — —
Interest Expense — — $1.2M
Pretax Income $-13.2M $-11.1M $-11.3M
Income Tax Expense $0 $0 $0
Net Income $-13.2M $-11.1M $-11.3M
Net Margin -4,574.4% — —
EPS (Basic) $-0.45 $-0.60 $-0.93
EPS (Diluted) $-0.45 $-0.60 $-0.93
Shares Outstanding (Basic) 29.6M 18.5M 12.1M
Shares Outstanding (Diluted) 29.6M 18.5M 12.1M
Dividends Per Share — — —